Epidemiology of liver cancer: An overview

Asian Pacific Journal of Cancer Prevention

Volumn 5, Issue 2, 2004, Pages 118-125

  Srivatanakul, Petcharin ^a   Sriplung, Hutcha ^b   Deerasamee, Somyos ^c  

^a NATIONAL CANCER INSTITUTE   (Thailand)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLISM; ASIA; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CAUSE OF DEATH; COMPARATIVE STUDY; FEMALE; HEALTH; HUMAN; INCIDENCE; INTRAHEPATIC BILE DUCT; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; PATHOLOGY; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL; THAILAND; VIRUS HEPATITIS;

ALCOHOLISM; ASIA; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CAUSE OF DEATH; CHOLANGIOCARCINOMA; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; THAILAND; WORLD HEALTH;

EID: 4344703262     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Akriviadis E, Llovet JM, Efremidis SC, et al. (1998). Hepatocellular carcinoma, Br J Surg, 85, 1319-31.
2. Bartsch H, Frank N (1996). Blocking the endogenous formation of N-nitroso compounds and related carcinogens, In: Principles of Chemoprevention, Stewart BW, McGregor D, Kleihues P (eds.). IARC Scientific Publications, No.139, International Agency for Research on Cancer, Lyon, 189-201.
3. Blair A, Kazerouni N (1997). Reactive chemicals and cancer, Cancer Causes Control, 8, 473-90.
4. Broome U, Lofberg R, Veress B, et al. (1995). Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology, 22, 1404-8.
5. Chang MH, Chen CJ, Lai MS, et al. (1997). Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children, Taiwan Childhood Hepatoma Study Group. N Engl J Med, 336, 1855-9.
6. Chen SY, Wang LY, Lunn RM, et al. (2002). Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer, 99, 14-21.
7. Corrao G, Arico S (1998). Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology, 27, 914-9.
8. Deerasamee S, Martin N, Sontipong S, et al. (1999). Cancer in Thailand Vol.II, 1992-1994, IARC Technical Report No.34, International Agency for Research on Cancer, Lyon.
9. Donato F, Tagger A, Chiesa R, et al. (1997). Brescia HCC Study, Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case - control study in Italy. Hepatology, 26, 579-84.
10. Fargion S, Mandelli C, Piperno A, et al. (1992). Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology, 15, 655-9.
11. Ferlay J, Parkin DM, Pisani P (1998). GLOBOCAN 1: Cancer Incidence and Mortality Worldwide, International Agency for Research on Cancer, Lyon.
12. Forman D, Vincent TJ, Doll R (1986). Cancer of the liver and the use of oral contraceptives. Br Med J, 292, 1357-61.
13. Fritz A, et al. eds.(2000). World Health Organisation, International Classification of Disease for Oncology, 3rd. ed., World Health Organization, Geneva.
14. Hamilton SR, Aaltonen LA, eds (1999). Pathology and Genetics of Tumours of the Digestive System, International Agency for Research on Cancer, Lyon, 158.
15. Harinasuta C, Harinasuta T (1984). Opisthorchis viverrini: life cycle, intermediate hosts, transmission to man and geographical distribution in Thailand. Arzneimittelforschung, 34, 1164-7.
16. Harrison PM (1999). Prevention of bile duct cancer in primary sclerosing cholangitis. Ann Oncol, 10, 208-11.
17. Haswell-Elkins MR, Mairiang E, Mairiang P, et al. (1994). Crosssectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer, 59, 505-9.
18. Hellerbrand C, Hartmann A, Richter G, et al. (2001). Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors. Dig Dis, 19, 345-51.
19. Henderson BE, Preston-Martin S, Edmondson HA, et al. (1983). Hepatocellular carcinoma and oral contraceptives. Br J Cancer, 48, 437-40.
20. Hirohashi S, Ishak KG, Kojiro M, et al. (1999). Hepatocellular carcinoma in: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System, International Agency for Research on Cancer, Lyon, 159-172.
21. Hollstein MC, Wild CP, Bleicher F, et al. (1992). p53 mutations and aflatonin B1 exposure in hepatocellular carcinoma patients from Thailand. Int J Cancer, 53, 1-5.
22. Honda N, Cobb C, Lechago J (1986). Bile duct carcinoma associated with multiple von Meyenburg complexes in the liver, Hum. Pathol, 17, 1287-90.
23. IARC (1993). Some naturally occurring substances: Food itemsand constituents, heterocyclic aromatic amines and mycotoxins, IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 56, International Agency for Research on Cancer, Lyon.
24. IARC (1994a). Hepatitis Viruses, IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 59, International Agency for Research on Cancer, Lyon
25. IARC (1994b). Schistosomes, Liver Flukes and Helicobacter pylori, IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 61, International Agency for Research on Cancer, Lyon, 121-175.
26. Ito Y, Kojiro M, Nakashima T, et al. (1988). Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer, 62, 1153-62.
27. Jones S ed. (1997). IARC / WHO, Cancer research for cancer control, 18-19.
28. Kobayashi M, Ikeda K, Saitoh S, et al. (2000). Incidence of primary cholangiocellular carcimoma of the liver in Japanese patients with hepatitis C virus related cirrhosis. Cancer, 88, 2471-7.
29. Lauret E, Rodriguez M, Gonzalez S, et al. (2002). HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma. Am J Gastroenterol, 97, 1016-21.
30. Lee MS, Kim DH, Kim H, et al. (1998). Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea. Int J Epidemiol, 27, 316-9.
31. Makimoto K, Higuchi S (1999). Alcohol consumption as a major risk factor for the rise in liver cancer mortality rates in Japanese men. Int J Epidemiol, 28, 30-4.
32. Mandishona E, MacPhail AP, Gordeuk VR, et al. (1998). Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans. Hepatology, 27, 1563-6.
33. Mant JW, Vessey MP (1995). Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives. Br J Cancer, 72, 800-3.
34. Martin N, Srisukho S, Kunpradist O, et al. (1998). Survival from Cancer in Chiang Mai, Thailand, In: Sankaranarayanan R, Black RJ, and Parkin DM, eds., Cancer survival in Developing Countries, IARC Scientific Publications No.145, International Agency for Research on Cancer, Lyon, 109-121.
35. McGlynn KA, Tsao L, Hsing AW, et al. (2001). International trends and patterns of primary liver cancer. Int J Cancer, 94, 290-6.
36. Migasena P, Changbumrung S (1974). The role of nitrosamines in the causation of primary carcinoma. J Med Assoc Thai, 57, 175-8.
37. Migasena P, Reaunsuwan W, Changbumrung S (1980). Nitrates and nitrites in local preserved protein foods. J Med Assoc Thai, 63, 500-5.
38. Migasena P, Changbumrung S, Tungtrongchitr R (1989). Evidence of chemical initiators and promoters in Thailand. In: Sornmani S, Bunnag T (eds.). Proceedings of the workshop in development of early diagnosis and management of cholangiocarcinoma associated with opisthorchiasis Faculty of Tropical Medicine, Mahidol University, Bangkok, 103-125.
39. Mizoue T, Tokui N, Nishisaka K, et al. (2000). Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region. Int J Epidemiol, 29, 232-7.
40. Montesano R, Hainaut P, Wild CP (1997). Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst, 89, 1844-51.
41. Nakanuma Y, Ohta G (1982). Pathological study of hepatolithiasis associated with intrahepatic cholangiocarcinoma, AnnualReport of Japanese Hepatolithiasis Study Group, 208-216.
42. Nakanuma Y, Sripa B, Vatanasapt V, et al. (1999). Intrahepatic cholangiocarcinoma in: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System, International Agency for Research on Cancer, Lyon, 173-180.
43. Neuberger J, Forman D, Doll R, et al. (1986). Oral contraceptives and hepatocellular carcinoma. Br Med J, 292, 1355-7.
44. Ohshima H, Bartsch H (1994). Chronic infections and inflammatory process as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res, 305, 253-64.
45. Parkin DM, Hakulinen T (1991). Analysis of Survival in: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, Cancer Registration Principles and Methods, International Agency for Research on Cancer, Lyon, 159-176.
46. Parkin DM, Srivatanakul P, Khlat M, et al. (1991). Liver cancer in Thailand, I. A. case-control study of cholangiocarcinoma. Int J Cancer, 48, 323-8.
47. Parkin DM, Ohshima H, Srivatanakul P, et al. (1993). Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention, Cancer Epidemiol. Biomarkers Prevention, 2, 537-44.
48. Parkin DM, Whelan SL, Ferlay J, et al. (1997). Cancer incidence in Five Continents Vol.VII. IARC Sci Publ, 143, 45-173.
49. Parkin DM, Pisani P, Ferlay J (1999). Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer, 827-841.
50. Parkin DM, Pisani P, Ferlay J (1999a). Global cancer statistics. CA Cancer J Clin, 49, 33-64.
51. Parkin DM, Pisani P, Munoz N, et al (1999b). The Global health burden of infection associated cancers. Cancer Surv, 33, 5-33.
52. Patel T (2002). Worldwide trends in mortality from biliary tract malignancies, BMC Cancer, 2, 10.
53. Pisani P, Parkin DM, Bray F, et al. (1999c). Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 83, 18-29.
54. Porru S, Placidi D, Carta A, et al. (2001). Primary liver cancer and occupation in men: a case-control study in a high-incidence area in Northern Italy. Int J Cancer, 94, 878-83.
55. Schafer DF, Sorrell MF (1999). Hepatocellular carcinoma. Lancet, 353, 1253-7.
56. Sharp GB, Cologne JB, Fukuhara T, et al. (2001). Temporal changes in liver cancer incidence rates in Japan, accounting for death certificate inaccuracies and improving diagnostic techniques. Int J Cancer, 93, 751-8.
57. Smanadhikorn P, Pongpaew P, Srivatanakul P, et al. (1995). Alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand. Southeast Asian J Trop Med Public Health, 26, 240-2.
58. Srivatanakul P, Sontipong S, Chotiwan P, et al. (1988). Liver cancer in Thailand: temporal and geographic variations, J. Gastroenterol. Hepatol, 3, 413-20.
59. Srivatanakul P, Ohshima H, Khlat M, et al. (1991a). Opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int J Cancer, 48, 821-5.
60. Srivatanakul P, Parkin DM, Khlat M, et al. (1991b). Liver cancer in Thailand, II A case-control study of Hepatocellular carcinoma. Int J Cancer, 48, 329-32.
61. Stocker JT, Schmidt D (1999). Hepatoblastoma in: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System, International Agency for Research on Cancer, Lyon, 184-189.
62. Sun Z, Lu P, Gail MH, et al. (1999). Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1, Hepatology, 30, 379-83.
63. Tomimatsu M, Ishiguro N, Taniai M, et al. (1993). Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular - cholangiocarcinoma) in Japan. Cancer, 72, 683-8.
64. Trichopoulos D, Day NE, Kaklamani E, et al. (1987). Hepatitis B virus, tobacco smoking and ethanol comsumption in the etiology of hepatocellular carcinoma. Int J Cancer, 39, 45-9.
65. Ugihara S, Kojiro M (1987). Pathology of cholangiocarcinoma, In: Neoplasms of the Liver, Okuda K, Ishak KG, eds., Springer -Verlag, Tokyo, 143-158.
66. van Leeuwen DJ, Reeders JW (1999). Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma. Ann Oncol, 10, 89-93.
67. Vatanasapt V, Martin N, Sriplung H, et al. (1993). Cancer in Thailand (1988-1991), IARC Technical Report No.16, International Agency for Research on Cancer, Lyon.
68. Vatanasapt V, Sriamporn S, Kamsaard S, et al. (1998). Survival from Cancer in Khon Kaen, Thailand. In: Sankaranarayanan R, Black RJ, and Parkin DM, eds, Cancer survival in Developing Countries, IARC Scientific Publications No.145, International Agency for Research on Cancer, Lyon, 123-134.
69. Waetjen LE, Grimes DA (1996). Oral contraceptives and primary liver cancer: temporal trends in three countries. Obstet Gynecol, 88, 945-949.
70. Wee A, Ludwig J, Coffey Jr RJ, et al. (1985). Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol, 16, 719-26.
71. Wittekind C, Fischer HP, Ponchon T (1999a). Bile Duct Cystadenoma and Cystadenocarcinoma in: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System, International Agency for Research on Cancer, Lyon, 182-183.
72. Wittekind C, Fischer HP, Ponchon T (1999b). Combined hepatocellular and cholangiocarcinoma in: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System, International Agency for Research on Cancer, Lyon, 181.
73. Yamamoto M, Takasaki K, Nakano M, et al. (1998). Minute nodular intrahepatic cholangiocarcinoma, Cancer, 82, 2145-2149.
74. Yamato T, Sasaki M, Hoso M, et al. (1998). Intrahepatic cholangiocarcinoma arising in congenital hepatic fibrosis: report of an autopsy case. J Hepatol, 28, 717-722.
75. Zhou H, Ortiz-Pallardo ME, Ko Y, et al. (2000). Is heterozygous alpha - 1 - antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma? Cancer, 88, 2668-76.